Company identity
Company number 05220538
Company profile
UK company 05220538, incorporated on 2 September 2004.
Learn what we do | Applied Nanodetectors Ltd
Transforming respiratory disease healthcare with our point of care breath platform. Our solution includes a device and software to deliver self-care programs.
Company number 05220538
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jan 2024 to 31 Mar 2024
Formaldehyde is a significant health risk, and International Agency for Research on Cancer (IARC) classifies formaldehyde as a human carcinogen. There are stringent formaldehyde exposure guidelines that exist for indoor air (80 ppb WHO) that can be even lower at the national level (e.g., France 8 ppb by 2023). People are exposed to formaldehyde from a var...
1 May 2023 to 31 Jul 2023
The project consists of an integrated software platform that provides connecting information for technical and non-technical stakeholders, facilitating the implementation and monitoring of Trustworthy AI within organisations. This platform comprises four main unique features: 1. Technical information platform 2. Non-technical information platform 3. Check...
1 Jul 2021 to 30 Jun 2022
Indoor air quality (IAQ) is one of the leading environmental risks, which affects people's, comfort, health, and well-being. People spend around 90% of their time indoors, and daily exposure to indoor air pollutants may occasionally be more than 10 times higher than outdoor pollutant (EPA). It is estimated, for instance, that up to 20% of the population s...
1 Oct 2020 to 31 Dec 2020
1 Jun 2020 to 31 Mar 2021
The COVID-19 pandemic raises particular challenges for the 400,000 UK care home residents, their families and the key staff that look after them. Recent guidance from the British Geriatric Society has been developed to help care home staff and NHS staff who work with them to support residents through the pandemic. This guidance recommends that where possi...
1 Jun 2020 to 31 Mar 2021
no public description
1 Apr 2019 to 30 Jun 2021
Chronic Obstructive Pulmonary Disease (COPD) and asthma are leading causes of morbidity and mortality worldwide and have a significant economic and social burden. Significant challenges include delays in an accurate diagnosis, maintaining good disease control and the identification of exacerbations, which consume a disproportionate share of expenditure du...
1 Feb 2019 to 31 Jan 2020
"Applied Nanodetectors (AND) propose to investigate the feasibility of a low cost fractional exhaled nitric oxide (FeNO) breath test for the diagnosis of asthma for use in primary care settings. The rapid and accurate diagnosis of asthma and identification of patients would be essential to ensure that adequate treatment, including hospitalisation when nec...
1 Jan 2019 to 31 Dec 2019
"We propose to investigate the feasibility of a point of care (POC) exhaled breath test for the diagnosis of asthma for use in primary care setting. The rapid and accurate diagnosis of asthma and identification of patients would be essential to ensure that adequate treatment, including hospitalisation when necessary, is implemented as early as possible. T...
1 Nov 2017 to 31 Mar 2019
Applied Nanodetectors has developed a sensor array platform that can be used for a number of market opportunities. Each sensor array is composed of different sensor elements produced using specific nanomaterials, which can be used for chemical and biosensors. This sensor array can be designed in the same physical space and allows forward integration into ...
1 Oct 2016 to 29 Feb 2020
Millennium Develop Goal 7c - to reduce by half the 4 billion people without sustainable access to safe drinking water - has encouraged rapid growth in water quality testing. Despite this, exposure to high levels of arsenic & fluoride through contaminated drinking water remains a global health problem, affecting an estimated 300m people worldwide & over 6m...
1 Jun 2015 to 30 Sep 2015
Chronic obstructive pulmonary disease (COPD) is a prevalent lung disease (3 Million in UK) that accounts for a major burden in the UK in terms of morbidity (25,000 deaths a year) and health care costs (£4bn). COPD is punctuated by exacerbations which are episodes of increased respiratory symptoms associated with systemic and airway inflammation. Most exac...